Latest Aquilo Capital Management, LLC Stock Portfolio
$133Million– No. of Holdings #10
Aquilo Capital Management, LLC Performance:
2024 Q1: 13.38%YTD: 13.38%2023: 16.2%
Performance for 2024 Q1 is 13.38%, and YTD is 13.38%, and 2023 is 16.2%.
About Aquilo Capital Management, LLC and 13F Hedge Fund Stock Holdings
Aquilo Capital Management, LLC is a hedge fund based in SAN FRANCISCO, CA. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $442.5 Millions. In it's latest 13F Holdings report, Aquilo Capital Management, LLC reported an equity portfolio of $133.4 Millions as of 31 Mar, 2024.
The top stock holdings of Aquilo Capital Management, LLC are ARWR, RGNX, BPMC. The fund has invested 19.5% of it's portfolio in ARROWHEAD PHARMACEUTICALS IN and 14.3% of portfolio in REGENXBIO INC.
They significantly reduced their stock positions in KYMERA THERAPEUTICS INC (KYMR), SILENCE THERAPEUTICS PLC (SLN) and BLUEPRINT MEDICINES CORP (BPMC). Aquilo Capital Management, LLC opened new stock positions in PRECISION BIOSCIENCES INC (DTIL). The fund showed a lot of confidence in some stocks as they added substantially to SUTRO BIOPHARMA INC (STRO) and REGENXBIO INC (RGNX).
The top stock holdings of Aquilo Capital Management, LLC are ARWR, RGNX, BPMC. The fund has invested 19.5% of it's portfolio in ARROWHEAD PHARMACEUTICALS IN and 14.3% of portfolio in REGENXBIO INC.
They significantly reduced their stock positions in KYMERA THERAPEUTICS INC (KYMR), SILENCE THERAPEUTICS PLC (SLN) and BLUEPRINT MEDICINES CORP (BPMC). Aquilo Capital Management, LLC opened new stock positions in PRECISION BIOSCIENCES INC (DTIL). The fund showed a lot of confidence in some stocks as they added substantially to SUTRO BIOPHARMA INC (STRO) and REGENXBIO INC (RGNX).
Aquilo Capital Management, LLC Equity Portfolio Value
Last Reported on: 15 May, 2024
Aquilo Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Aquilo Capital Management, LLC made a return of 13.38% in the last quarter. In trailing 12 months, it's portfolio return was 43.77%.
New Buys
| Ticker | $ Bought |
|---|---|
| precision biosciences inc | 5,226,570 |
New stocks bought by Aquilo Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| sutro biopharma inc | 177 |
| regenxbio inc | 12.94 |
Additions to existing portfolio by Aquilo Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| kymera therapeutics inc | -55.89 |
| silence therapeutics plc | -44.96 |
| blueprint medicines corp | -28.52 |
| merus n v | -28.16 |
| arvinas inc | -17.05 |
Aquilo Capital Management, LLC reduced stake in above stock
Sold off
Sector Distribution
Aquilo Capital Management, LLC has about 90.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 90.7 |
| Others | 9.3 |
Market Cap. Distribution
Aquilo Capital Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 53.6 |
| SMALL-CAP | 31 |
| UNALLOCATED | 9.3 |
| MICRO-CAP | 6.2 |
Stocks belong to which Index?
About 75.9% of the stocks held by Aquilo Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 75.9 |
| Others | 24.1 |
Aquilo Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Aquilo Capital Management, LLC
Aquilo Capital Management, LLC has 10 stocks in it's portfolio. ARWR proved to be the most loss making stock for the portfolio. KYMR was the most profitable stock for Aquilo Capital Management, LLC last quarter.
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ARVN | arvinas inc | 12.55 | 405,766 | 16,750,000 | reduced | -17.05 | ||
| ARWR | arrowhead pharmaceuticals in | 19.47 | 908,474 | 25,982,400 | unchanged | 0.00 | ||
| BPMC | blueprint medicines corp | 12.95 | 182,151 | 17,278,800 | reduced | -28.52 | ||
| DTIL | precision biosciences inc | 3.92 | 385,440 | 5,226,570 | new | |||
| KYMR | kymera therapeutics inc | 11.71 | 388,743 | 15,627,500 | reduced | -55.89 | ||
| MRUS | merus n v | 8.61 | 255,109 | 11,487,600 | reduced | -28.16 | ||
| RGNX | regenxbio inc | 14.31 | 906,248 | 19,094,600 | added | 12.94 | ||
| RPTX | repare therapeutics inc | 2.24 | 633,271 | 2,982,710 | unchanged | 0.00 | ||
| SLN | silence therapeutics plc | 9.30 | 574,214 | 12,403,000 | reduced | -44.96 | ||
| STRO | sutro biopharma inc | 4.94 | 1,165,470 | 6,584,880 | added | 177 | ||